Vivos Therapeutics, Inc. (VVOS)

NASDAQ: VVOS · Real-Time Price · USD

1.830

0.00 (0.00%)

At close: Jan 22, 2026, 4:00 PM EST

1.880

+0.050 (2.72%)

After-hours: Jan 22, 2026, 5:30 PM EST

Vivos Therapeutics Analyst Ratings

Total Analysts

2

Consensus Rating

Strong Buy

Price Target

$6.25

Upside

+241.53%

Ratings History

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Lucas Ward Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $6.5 → $5.5	Strong Buy	Maintains	$6.5 → $5.5	+200.55%	Dec 3, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $7	Strong Buy	Initiates	$7	+282.51%	Nov 17, 2025
Lucas Ward Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $6.2 → $6.5	Strong Buy	Maintains	$6.2 → $6.5	+255.19%	Sep 9, 2025
Lucas Ward Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $6.6 → $6.2	Strong Buy	Maintains	$6.6 → $6.2	+238.80%	Apr 15, 2025
Lucas Ward Ascendiant Capital	Ascendiant Capital	Strong Buy Reiterates $6.6	Strong Buy	Reiterates	$6.6	+260.66%	Nov 20, 2024
Scott Henry Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $8.25 → $6	Strong Buy	Maintains	$8.25 → $6	+227.87%	Nov 19, 2024
Lucas Ward Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $6.4 → $6.6	Strong Buy	Maintains	$6.4 → $6.6	+260.66%	Aug 20, 2024
Edward Woo Ascendiant Capital	Ascendiant Capital	Strong Buy Initiates $63	Strong Buy	Initiates	$63	+3,315.30%	Jan 17, 2023
Scott Henry Roth Capital	Roth Capital	Strong Buy Maintains $275 → $250	Strong Buy	Maintains	$275 → $250	+13,561.20%	Aug 13, 2021
Scott Henry Roth Capital	Roth Capital	Strong Buy Maintains $300 → $275	Strong Buy	Maintains	$300 → $275	+14,927.32%	May 18, 2021
Alexander Nowak Craig-Hallum	Craig-Hallum	Strong Buy Initiates $300	Strong Buy	Initiates	$300	+16,293.44%	Jan 11, 2021
Scott Henry Roth Capital	Roth Capital	Strong Buy Initiates $300	Strong Buy	Initiates	$300	+16,293.44%	Jan 5, 2021